US Patent Issued to CytomX Therapeutics on Sept. 30 for "Compositions containing activatable antibodies" (California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,470, issued on Sept. 30, was assigned to CytomX Therapeutics Inc. (South San Francisco, Calif.).

"Compositions containing activatable antibodies" was invented by Sarah Patrick (Menlo Park, Calif.), Claus Krebber (Palo Alto, Calif.), Sridhar Viswanathan (Menlo Park, Calif.), Shanti Gonela Duvur (Fremont, Calif.) and Eric Ureno (Daly City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a composition including an intact activatable antibody and a clipped variant thereof, methods of separating clipped variants of intact activatable antibodies from intact activatable antibodies and related methods including methods for dete...